[Previously posted, and front-paged, at Congress Matters.]
The 110th Congress passed a number of good legislative items in 2007 and 2008 that went on to be vetoed by President Bush, among them two versions of SCHIP expansion and the Stem Cell Research Enhancement Act of 2007. These bills had relatively solid Democratic support and some conspicuous Republican crossovers, but were not able to garner veto-proof majorities. If you consider the number of good bills that passed the Dem-dominated House but died on a cloture vote in the Senate, more issues come to light, notably the Employee Free Choice Act, which nabbed a mere 51 Senate votes for cloture.
But President-elect Obama 1) won't veto these kinds of bills, and 2) will enjoy heftier Democratic majorities in both chambers. Many Senate cloture votes that had 53 or more on the "pro" side will now have the 60 necessary to shut down debate. Thus, bills like the Employee Free Choice Act, Stem Cell Research Enhancement Act, and SCHIP expansion would be easy to get through Congress come January 2009.
The dilemma becomes this...
Read More